11 September, 2024
Karo Healthcare appoints Egil Mølsted Madsen as CFO
We are pleased to announce that Egil Mølsted Madsen will assume the role of CFO at Karo starting on 3 October 2024. Egil, a Danish national, brings a wealth of...
News from Karo Pharma
15 April, 2024
Karo Group publishes the 2023 Sustainability Report
Today, on 15 April 2024, Karo Group* is publishing its 2023 Sustainability Report on the company’s website, www.karohealthcare.com. For further information, please contact: Christoffer Lorenzen, CEO, +46 735 017 620,...
6 March, 2024
Karo Healthcare expands its presence in Italy with the acquisition of the rights to Proctosedyl® from Bayer
Karo Healthcare AB (‘Karo’) announces the acquisition of the rights to the OTC brand Proctosedyl from Bayer. The transaction transfers global dossier ownership to the OTC pharmaceutical Proctosedyl, and exclusive...